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Abstract
Objective—Cervical cancer remains a leading cause of death in many developing countries due 
to limited screening by Papanicolaou (Pap) smear. We sought to better understand women’s 
beliefs about cervical cancer and screening in Botswana, a middle income African country with 
high rates of cervical cancer.
Methods—We interviewed 289 women attending general medicine or human immunodeficiency 
virus (HIV) clinics, where Pap testing was available, in Gaborone, Botswana in January 2009.
Results—About three-quarters (72%) of respondents reported having ever had a Pap smear. 
HIV-positive women were more likely to have had a Pap smear than HIV-negative women (80% 
vs. 64%, OR=1.97, 95% CI: 1.10, 3.55). Screening was also more common among women who 
were older, had higher incomes, or had heard of cervical cancer. Almost all participants reported a 
desire to have a Pap smear. Reasons included to determine cervical health (56%), to improve 
overall health (33%), and to obtain early treatment (34%). About half (54%) of respondents said 
they did not know what causes cervical cancer, and almost none attributed the disease to HPV 
infection.
Conclusion—Study findings can inform interventions that seek to increase cervical cancer 
awareness and uptake of screening as it becomes more widely available.
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Introduction
Cervical cancer is the second most common cancer among women worldwide, with about 
80% of the cases occurring in less-developed countries.1 North America and Europe have 
age-standardized incidence rates of about 6 and 11 cases of cervical cancer per 100,000 
woman-years, respectively, while sub-Saharan Africa has one of the highest incidence rates 
at 32 cases per 100,000 woman-years.2 Mortality rates in the US are very low at 2 cases per 
100,000 woman-years compared to the high rate in sub-Saharan Africa of 23 cases per 
100,000 woman-years.2 In sub-Saharan Africa, cervical cancer makes up the largest 
proportion of years of life lost due to cancer,1 because of its typically young age at onset, 
between 35 and 50 years.3
The human immunodeficiency virus (HIV) and acquired immune deficiency syndrome 
(AIDS) epidemic in sub-Saharan Africa contributes to the high prevalence of HPV infection 
and cervical cancer as women infected with HIV are at increased risk of acquiring infection 
with HPV.4 HIV-positive women are also six times more likely to develop cervical cancer 
compared to those not infected with HIV,5 and cervical cancer is considered an AIDS 
defining illness.6
While cervical cancer incidence rates have decreased dramatically in developed nations over 
the past 40 years, incidence rates remain stable in less-developed countries, including those 
in sub-Saharan Africa. This results from a lack of screening implementation or, where 
implemented, poor screening coverage and quality.1 Severely limited health resources make 
it difficult to transfer successful approaches to cervical cancer prevention and treatment 
from developed country settings.7 As a result, women may frequently go undiagnosed until 
cervical disease has reached an advanced and untreatable stage. In developing countries, the 
majority of cases are diagnosed at a late stage of disease,8 with as many as 80% of cervical 
cancer cases diagnosed at stage III or higher.9
Cervical cancer screening in Botswana is similarly limited and currently unable to reduce 
the disease burden. The country lacks the general infrastructure to support widespread 
screening and subsequent recall of women who have tested positive to receive follow-on 
treatment. Existing screening resources are concentrated in urban areas, where screening is 
typically opportunistic, with many screenings performed on women previously screened. 
Thus, the majority of women presenting with cervical cancer are those who have never been 
screened.
This study investigated prior receipt of a Papanicolaou (Pap) smear among women seeking 
health care in Gaborone, Botswana in clinics with access to Pap screening services. The 
study also examined women’s beliefs about causes of cervical cancer and reasons for 
undergoing a Pap smear. We hypothesized that HIV-positive women would be more likely 
to have had a Pap smear than HIV-negative women, because they are more involved in 
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health care services. We also hypothesized that women with higher incomes would be more 
likely to have had a Pap smear due to greater resources to seek and obtain the health care 
services that they need.
Methods
Participants and Procedures
In January 2009, interviewers identified potential study participants at two public health 
clinics in Gaborone, the capital of Botswana. An HIV clinic provided highly subsidized care 
to individuals living with HIV, and a general medicine clinic provided highly subsidized 
care to all adult citizens. Both clinics had access to Pap smear services. While 376 adults 
completed the questionnaire, we report results from 289 female respondents (77% of total 
participants) who answered questions about cervical cancer.
Local Batswana high school graduates conducted interviews as part of a capacity building 
collaboration with the Batswana government. Interviewers received training about cervical 
cancer and appropriate translations for medical terminology from a Motswana obstetrics and 
gynecology physician. They memorized scripts to achieve consistency during introductions, 
interviews, and informed consent and received constructive criticism throughout the 
interview month. The three interviewers rotated among study sites and three experienced 
research nurses affiliated with the Botswana-UPenn Partnership, provided supervision.
On weekday mornings, patients waited to see a provider in a large general seating area on a 
first come, first served basis. Interviewers asked people interested in volunteering to join the 
study to raise their hands and later obtained verbal consent. About half of the adults 
attending the clinics participated in the study. Participants received no monetary, food, or 
other incentives for completing the questionnaire. Interviewers offered questionnaires in 
either Setswana or English, interviewers read the questionnaire for the few individuals that 
self-identified as unable to read or who preferred this option. The Institutional Review 
Boards at the University of Pennsylvania, Princess Marina Hospital, and the Botswana 
Ministry of Health approved this study.
Measures
A native Motswana resident translated the English questionnaire to and from Setswana with 
the assistance of a Motswana obstetrics and gynecology physician. We resolved 
discrepancies through discussion. The cultural appropriateness of the content and general 
reading level was initially tested with three Batswana women, both lay people and medical 
staff. Based on these interviews, we made final revisions to the questionnaire, which totaled 
five pages. The questionnaire is available online at http://www.unc.edu/~ntbrewer/hpv.htm.
The main outcome measure was self-report of ever having had a Pap smear. The 
questionnaire provided participants with a brief written explanation on the purpose of a Pap 
smear and how doctors perform the test. The questionnaire then asked women if they had 
ever had a Pap smear and if they were willing to get a Pap smear in the next year. The 
questionnaire asked participants to list the reason why they would or would not be willing to 
get a Pap smear in the next year, accompanied by three short answer spaces for responses. 
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Participants were also asked to list up to three things that can cause cervical cancer. Three 
people independently translated each of the short answer responses from Setswana to 
English. Any discrepancies were subsequently discussed and resolved to obtain the most 
accurate translation of the response.
Data Analysis
We used bivariate logistic regression models to examine correlates of women having ever 
had a Pap smear. We entered statistically significant (p<0.05) covariates in a multivariate 
logistic regression model using a forward stepwise procedure, as a simultaneous regression 
model was unstable. Our oversampling of persons with HIV prompted us to explore 
interactions with HIV status. As interaction terms were not statistically significant at a level 
greater than chance, we do not discuss the issue further. We analyzed data using SPSS 
version 19.0 (SPSS Inc., Chicago IL). All statistical tests were two-tailed, using a critical 
alpha of 0.05.
Results
About three-quarters (71%) of participants were over 30 years of age (Table 1). Women’s 
education levels were distributed about equally between three levels: primary education or 
less (35%), secondary education (43%), or tertiary and higher (22%). Half of all respondents 
(53%) had no regular monthly income, and another 30% made less than 2500 pula (~$360 
US) per month, an amount considered low income by Batswana federal government tax 
bracket.10 Similar numbers of female respondents were from the general medicine and HIV 
clinics. Around half of respondents (56%) reported infection with HIV. Nine percent 
reported a history of genital warts, and 24% reported a history of sexually transmitted 
infections. Women seen at the HIV clinic were older, less likely to be currently married, less 
educated, less wealthy and more likely to have had genital warts or sexually transmitted 
infections than those seen at the general medicine clinic (all p<.05).
Cervical cancer
Most (77%) of respondents had heard of cervical cancer prior to the questionnaire and 18% 
knew someone with cervical cancer. Ten percent of the women (n=29) stated they had a 
personal history of cervical cancer. Of these women, 20 reported being infected with HIV, 
and 9 stated they were HIV-negative. Just over one-third (37%) of the respondents had heard 
of HPV prior to the questionnaire.
When asked to list up to three causes of cervical cancer, 54% of the respondents included “I 
don’t know” as a response (Table 2). The most common causes mentioned were unprotected 
sex or HIV (40%), vaginal or genital infections (38%), inserting foreign matter in the vagina 
(19%), and multiple sex partners (15%). Only 3 respondents (1%) identified HPV as the 
cause of cervical cancer. When asked how HIV infection affected the risk of cervical cancer, 
less than half (47%) of respondents said they believed that HIV infection increases the risk.
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Most women (72%) reported having had a Pap smear in the past. Almost all women (95%) 
reported that they would be willing to have a Pap smear if given the opportunity. Reasons 
for desiring a Pap smear included to determine cervical health (56%), to improve overall 
health (33%), to obtain early treatment (34%), and because of symptoms (10%) (Table 3).
In multivariate analysis that included age, income, HIV diagnosis, and prior knowledge of 
cervical cancer, women over 30 years of age were more likely to have had a Pap smear than 
younger women (OR=1.99, 95% CI: 1.07, 3.71) (Table 4). Women earning a regular income 
were more likely to have had a Pap smear than those without a regular income source 
(OR=1.90, 95% CI: 1.05, 3.46). HIV-positive women were more likely to have had a Pap 
smear than HIV-negative women (OR=1.97, 95% CI: 1.10, 3.55). Women who had 
previously heard of cervical cancer were more likely to have had a Pap smear than those 
who had not heard of cervical cancer (OR=3.28, 95% CI: 1.73, 6.24). Attending the HIV 
clinic and having children were associated with having had a Pap smear in bivariate 
analyses, but not in the multivariate analysis.
Discussion
Nearly all women in our study were willing to receive a Pap smear if the procedure were 
offered to them. Motivations for testing included assessing personal cervical health, 
improving overall health, and determining if treatment is necessary. This nearly universal 
enthusiasm for cervical cancer screening is encouraging and is similar to other countries. A 
national survey of older adults in the United States found that 87% believed that routine 
cancer screening is almost always a good idea.11 The enthusiasm for cancer screening in 
Botswana suggests that there will likely be high uptake of Pap smear as it becomes more 
widely available.
Cytology registers at the 2 referral labs in the country documented around 10,000 Pap smear 
slides registered in 2005, compared to around 43,000 slides in 2010 (D. Ramogola-Masire, 
personal communication). However, many of the women screened had received multiple 
tests possibly due to inadequate specimen or concomitant infection. As roughly 150,000 
Batswana women need screening each year, current prevention services are clearly 
inadequate. While Pap smears can be expensive, other lower cost screening methods may be 
more suitable for low resource settings. These include the acetowhite test, visual inspection 
after application of 3–5% acetic acid and the same procedure with magnification. The VIA 
technique has a higher sensitivity but lower specificity as compared to Pap smears12, and all 
methods of cervical inspection require substantial training of the provider. In addition, 
testing for human papillomavirus (HPV) infection, the main cause of cervical cancer, is 
available for cervical cancer screening of women 30 years of age and over, and has been 
shown to have a notably higher sensitivity, yet lower specificity than Pap smear testing.13 
Given the relatively high negative predictive value of HPV testing for future risk of high-
grade cervical neoplasia, it may also be another option to be considered in less-developed 
countries. Our study focused on the Pap smear, because it was the procedure available at the 
study sites.
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Self-reported prevalence of history of Pap smear was 72% among Batswana women 
attending two clinics that were attached to a larger hospital with a dedicated Pap smear 
clinic. Patients from both clinics could be referred for Pap smear within these clinical 
settings; therefore, these patients were almost certainly more likely than anywhere else in 
the country to have had a Pap smear given the limited availability of cervical cancer 
screening elsewhere in Botswana. Pap smear use was higher among women from the HIV 
clinic than the general medicine clinic, perhaps due the greater indications for cervical 
cancer screening of HIV-positive women. Analyses controlled for variables, including 
income, on which the clinics differed and that were also associated with Pap use.
A recent meta-analysis of accuracy of self-reported cancer screening histories found high 
sensitivity of Pap smear self-reporting but low specificity, with the most over-reporting 
among minority and low-income women.14 Thus, self-reported histories may over-estimate 
testing prevalence, because women may not know whether a doctor performed a Pap smear, 
a pelvic exam or some other procedure. While we acknowledge this potential weakness, we 
also believe the information on beliefs about testing and cervical cancer and correlates of 
screening are especially valuable.
The prevalence of Pap smear testing is lower in other studies in sub-Saharan Africa. A study 
in South Africa found that 41% of women in a clinic reported that they had had ever had a 
Pap smear.15 This difference may be due to higher availability of Pap smear services and our 
sample having a high prevalence of HIV-positive women who had more frequent contact 
with local clinics resulting in higher prevalence of cervical cancer screening.
Women who reported having been previously screened for cervical cancer were more likely 
to be older, HIV-positive, receiving a regular income, and have heard of cervical cancer. 
Other studies have found similar correlates. In Tanzania, women pursuing cervical cancer 
screening were more likely to be non-agriculturally employed and thus have a secure, 
regular income.16 Older Mexican women living near the US border were more likely to have 
had a Pap smear.17 Understanding the characteristics of women who have had a Pap smear 
is important to identifying women who are missed in screening programs. Interventions can 
be targeted toward these women to improve the population’s overall health.
Only around half of our respondents linked Pap smears to cervical health or cervical cancer. 
As we expected women would have low knowledge, the questionnaire provided a brief, 
general description of the purpose of Pap smear testing and how one is performed, prior to 
asking about Pap smear history and willingness and reasons to get a Pap smear. We included 
this educational brief to increase the reliability of responses about having had a Pap smear 
by standardizing the definition of the test for study participants, though including this 
information may have also led to overestimates of knowledge. A previous study in 
Botswana found that of 30 women surveyed, 10 had appropriate understanding of Pap smear 
testing while 8 were able to only define the test, 8 had merely heard of the test, and 4 had 
not heard of Pap smears.18 Similarly low numbers exist in other developing countries with 
about 30% of women having heard of Pap smears. 8,19 Of these, 11% to 33% knew the test 
was used to detect cervical cancer.8,19
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Batswana women’s awareness of cervical cancer is similar to or higher than levels in other 
developing countries. In our study, around three quarters of women had heard of cervical 
cancer. In other studies in developing countries, 12% to 61% of those surveyed had heard of 
cervical cancer.8,15,19 Many Batswana women did not understand the link between HIV or 
HPV infection and cervical cancer. In our study, less than half of the participants had heard 
of HPV, and only three women linked it to cervical cancer. However, half of women listed 
causes of cervical cancer that correctly identified sexual behaviors that increase the risk of 
HPV infection and thus cervical cancer. Studies in other developing countries found that of 
women who had heard of cervical cancer, 12% to 32% of women identified HPV as a risk 
factor.8,19
These low figures show a widespread lack of understanding of cervical health among 
women in Botswana. Existing education programs are increasing awareness of common 
health terms but may not be helping women to understand important risk factors and 
consequences. Improved health education may be needed for women in Botswana to 
increase motivation to seek Pap smears even when obstacles exist. Focus groups in Malaysia 
revealed that, while only 3% of women knew that HPV causes cervical cancer, many desired 
a basic understanding on how HPV causes cervical cancer, the symptoms, and treatment 
options.20
Our study findings provide a greater understanding of Batswana women’s relationship to 
cervical cancer and screening. As prevention capacity increases, local agencies can use this 
information to design interventions to increase cervical cancer screening in women not 
likely to have received Pap smears in the past. They can also develop educational programs 
that increase not only cervical cancer awareness but also highlight HPV as a risk factor, 
making the connection between the infection and the disease. This education will become 
increasingly important in order to encourage acceptance of the HPV vaccine as it is 
introduced into developing country settings.
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Table 1





n (%) n (%) n (%)
Age*
   20–30 years 30 (21) 54 (36) 84 (29)
   31–84 years 110 (79) 94 (64) 204 (71)
Marital status*
   Never married 99 (71) 92 (62) 191 (66)
   Married or living as married 24 (17) 45 (30) 69 (24)
   Divorced, widowed, or separated 17 (12) 12  (8) 29 (10)
Have children
   No 19 (14) 26 (17) 45(16)
   Yes 121 (86) 123 (83) 244 (84)
Education*
   Primary education or less 58 (42) 42 (28) 100 (35)
   Secondary education 62 (45) 63 (42) 125 (43)
   Tertiary education or more 19 (14) 44 (30) 63 (22)
Monthly income*
   No regular income 69 (51) 77 (53) 146 (52)
   <$360 (2500 pula) 49 (36) 36 (25) 85 (30)
   ≥$360 (2500 pula) 18 (13) 33 (23) 51 (18)
Distance from capital (Gaborone)
   0–30 km 89 (65) 93 (64) 182 (64)
   >30 km 48 (35) 53 (36) 101 (36)
Had cervical cancer 18 (13) 11   (7) 29 (10)
Had genital warts* 19 (14) 7  (5) 26  (9)
Had sexually transmitted infection* 49 (35) 20 (14) 69 (24)
HIV status*
   Negative 7  (5) 110 (74) 117 (41)
   Positive 132 (94) 31 (21) 163 (56)
   Never tested/ Not reported 1  (1) 8  (5) 9  (3)
Note. HIV = human immunodeficiency virus
*
p<0.05
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Table 2
Beliefs about causes of cervical cancer (n=289)
%
Don’t know 54
Unprotected sex or HIV 40
Vaginal/genital infections 38
Introducing foreign matter into vagina† 19
Multiple sex partners 15
Poor general hygiene or diet 8
Gynecologic problems 6
Smoking or alcohol use 4
Heredity 2
HPV 1
Note. Participants could list up to three causes. HIV = human immunodeficiency virus, HPV = human papillomavirus
†
Traditional herbs, douching, contraceptive, chemicals, and objects placed in the vagina
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Table 3
Reasons for desiring a Pap smear (n=289)
%
To know if cervix is healthy 56
To get early treatment 34
Improve overall health 33
Had symptoms 10
To know if can have children 8
Other 9
Note. Participants could list up to three reasons. Responses in the “other” category included to be a role model, to receive education, and to check 
for infection
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Overall 208/287 (72) -- --
Demographic Characteristics
Age
   20–30 years 50/ 84 (60) ref. ref.
   31–84 years 158/202 (78) 2.44 (1.41–4.23)* 1.99 (1.07–3.71)*
Ever married
   No 131/190 (69) ref. --
   Yes 77/ 97 (79) 1.73 (0.97–3.10)
Have children
   No 26/ 45 (58) ref. --
   Yes 182/242 (75) 2.22 (1.15–4.29)*
More than primary education
   No 70/ 98 (71) ref. --
   Yes 137/188 (73) 1.08 (0.62–1.85)
Regular income
   No 102/153 (67) ref. ref.
   Yes 104/132 (79) 1.86 (1.09–3.17)* 1.90 (1.05–3.46)*
Monthly income ≥ $360
   No 62/ 83 (75) ref. --
   Yes 44/ 51 (86) 2.13 (0.83–5.44)
Distance from capital (Gaborone)
   0–30 km 133/180 (74) ref. --
   > 30 km 71/101 (70) 0.84 (0.49–1.44)
Study Site
   General medicine clinic 98/148 (66) ref. --
   HIV clinic 110/139 (79) 1.94 (1.14–3.30)*
Personal Health
Had cervical cancer
   No 184/255 (72) ref. --
   Yes 22/ 29 (76) 1.21 (0.50–2.96)
Had genital warts
   No 186/258 (72) ref. --
   Yes 20/ 26 (77) 1.29 (0.50–3.34)
Had sexually transmitted infection
   No 151/216 (70) ref. --
   Yes 54/ 68 (79) 1.66 (0.86–3.20)























   Negative 74/116 (64) ref. ref.
   Positive 130/162 (80) 2.31 (1.34–3.96)* 1.97 (1.10–3.55)*
HPV and Cervical Cancer Beliefs
Heard of HPV
   No 127/178 (71) ref. --
   Yes 78/105 (74) 1.16 (0.67–2.00)
Heard of cervical cancer
   No 32/ 59 (54) ref. ref.
   Yes 172/221 (78) 2.96 (1.62–5.41)* 3.28 (1.73–6.24)*
Knew someone with cervical cancer
   No 166/236 (70) ref. --
   Yes 41/ 50 (82) 1.92 (0.89–4.16)
HIV infection’s effect on risk of developing cervical cancer
   No effect/lowers risk 31/ 40 (78) ref. --
   Raises risk 109/136 (80) 1.17 (0.50–2.75)
   Don’t know/No answer 68/111 (61) 0.46 (0.20–1.06)
Note. HPV = human papillomavirus, OR = odds ratio, CI = confidence interval, ref. =referent group, HIV = human immunodeficiency virus.
*
p<0.05
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